Top compounds associated with response to E2F5


Feature Type Standardized
Nominal ANOVA
mRNA BRD-A86708339 CTRPv2 pan-cancer AAC 0.23 1e-05
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA AZD6244 CTRPv2 pan-cancer AAC -0.15 2e-05
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 2e-05
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 3e-05
mRNA AC220 GDSC1000 pan-cancer AAC -0.15 3e-05
mRNA OSI-027 GDSC1000 pan-cancer AAC 0.13 3e-05
mRNA erismodegib CTRPv2 pan-cancer AAC 0.16 3e-05
mRNA myricetin CTRPv2 pan-cancer AAC 0.16 5e-05
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 5e-05
Download CSV